Crossmark

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2024.11.007

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vigara, Luis Alberto https://orcid.org/0000-0001-6568-6160
Villanego, Florentino https://orcid.org/0000-0002-7828-9479
Orellana, Cristhian https://orcid.org/0000-0001-7820-8387
Eady, Myriam

Sánchez, María Gabriela

Alonso, Marta https://orcid.org/0000-0001-8270-9037
García, María Belén

Amaro, José Manuel https://orcid.org/0000-0003-3274-3426
García, Teresa https://orcid.org/0000-0002-2491-3221
Mazuecos, Auxiliadora https://orcid.org/0000-0002-5860-2309
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-11-16
More Information

This article is maintained by: Elsevier

Article Title: Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2024.11.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nefro.2023.06.010

Content Type: article

Copyright: © 2023 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.